Vanguard Group Inc Sonoma Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$2.65 - $4.12 $17,020 - $26,462	6,423 Added 23.28%	34,014 $99,000
Q1 2022 May 13, 2022	SELL	$2.65 - $4.84 $71,960 - $131,430	-27,155 Reduced 49.6%	27,591 $111,000
Q4 2021 Feb 14, 2022	BUY	$4.32 - $6.27 $115,650 - $167,854	26,771 Added 95.7%	54,746 $250,000
Q2 2021 Aug 13, 2021	BUY	$7.12 - $9.15 $199,182 - $255,971	27,975 New	27,975 $205,000

2.27K

Ticker SNOA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,100,940
Market Cap $8.84M
Description
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.